CATTANEO, DARIO
 Distribuzione geografica
Continente #
SA - Sud America 2.004
AS - Asia 1.917
NA - Nord America 448
EU - Europa 134
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.596
Nazione #
BR - Brasile 1.604
VN - Vietnam 892
SG - Singapore 671
US - Stati Uniti d'America 372
AR - Argentina 182
CN - Cina 104
ID - Indonesia 90
EC - Ecuador 80
BD - Bangladesh 52
MX - Messico 45
PY - Paraguay 38
ZA - Sudafrica 38
CO - Colombia 37
RU - Federazione Russa 37
IT - Italia 31
CL - Cile 24
HK - Hong Kong 21
IQ - Iraq 20
UA - Ucraina 19
PE - Perù 14
VE - Venezuela 14
EG - Egitto 12
IN - India 10
MA - Marocco 10
DZ - Algeria 9
UY - Uruguay 8
UZ - Uzbekistan 8
CA - Canada 7
DO - Repubblica Dominicana 7
AZ - Azerbaigian 6
IE - Irlanda 6
KE - Kenya 6
GB - Regno Unito 5
JP - Giappone 5
SI - Slovenia 5
TN - Tunisia 5
AL - Albania 4
NP - Nepal 4
PK - Pakistan 4
SN - Senegal 4
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DE - Germania 3
FR - Francia 3
GT - Guatemala 3
IL - Israele 3
KW - Kuwait 3
LB - Libano 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
FI - Finlandia 2
JM - Giamaica 2
KZ - Kazakistan 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
PL - Polonia 2
QA - Qatar 2
SE - Svezia 2
SV - El Salvador 2
TR - Turchia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
ES - Italia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LT - Lituania 1
NI - Nicaragua 1
NL - Olanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 4.596
Città #
Ho Chi Minh City 354
Dallas 172
Hanoi 165
São Paulo 117
Ashburn 96
Rio de Janeiro 57
Beijing 51
Da Nang 41
Singapore 39
Haiphong 35
Biên Hòa 34
Curitiba 33
Brasília 28
Porto Alegre 27
Hải Dương 26
Guayaquil 25
Thái Bình 25
Belo Horizonte 23
Quito 23
Campinas 21
Hong Kong 21
Salvador 20
Ribeirão Preto 19
Assago 18
Guarulhos 18
Fortaleza 17
Ninh Bình 16
Buenos Aires 15
Johannesburg 15
Santo André 15
Sorocaba 15
Can Tho 14
Jakarta 14
Manaus 13
Mexico City 12
Resistencia 12
Bogotá 11
Goiânia 11
Thái Nguyên 11
Viamão 11
Wilmington 11
Asunción 10
Belém 10
Bắc Giang 10
Cape Town 10
Caxias do Sul 10
Lấp Vò 10
Phủ Lý 10
Cotia 9
Piracicaba 9
São Gonçalo 9
Guarujá 8
Ha Long 8
Hortolândia 8
Juiz de Fora 8
Mauá 8
New York 8
Pelotas 8
Quảng Ngãi 8
Santiago 8
Sumaré 8
Bandung 7
Cairo 7
Carapicuíba 7
Dhaka 7
Franca 7
Huế 7
Lima 7
Medellín 7
Montes Claros 7
Osasco 7
Suzano 7
São Bernardo do Campo 7
São José do Rio Preto 7
Volta Redonda 7
Barra Mansa 6
Bắc Ninh 6
Caracas 6
Colombo 6
Denpasar 6
Dublin 6
Indaiatuba 6
Ribeirão das Neves 6
Shanghai 6
São Leopoldo 6
Tashkent 6
Americana 5
Aparecida de Goiânia 5
Baghdad 5
Baku 5
Bình Dương 5
Chandler 5
Council Bluffs 5
Duque de Caxias 5
Feira de Santana 5
Gramado 5
Guaratuba 5
Itabira 5
Joinville 5
Jundiaí 5
Totale 2.112
Nome #
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. 65
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial 45
"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study 27
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients 25
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 25
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication 24
Are non-serious adverse reactions to psychiatric drugs really non-serious ? 24
Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing 24
Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma 24
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis 24
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report 23
Psychoactive drugs and HIV: are we sure to treat our patients adequately? 23
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine 23
Two-hour blood cyclosporine level does not necessarily predict drug exposure and graft function outcome in stable kidney transplant recipients 23
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 23
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 23
A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries 22
Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection 22
Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor-Free Regimen 22
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies 22
Pharmacogenomics of immunosuppressive agents: perspective for individualized therapy 22
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 22
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out 21
Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs 21
Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review 21
Aldosterone and progression of kidney disease 21
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients 21
Antibiotic Therapy Strategies for Treating Gram- Negative Severe Infections in the Critically Ill: A Narrative Review. 21
Transplacental passage of ritonavir-boosted darunavir in two pregnant women 21
Does lopinavir really inhibit SARS-CoV-2? 21
Multidrug-resistant HIV viral rebound during early syphilis: a case report 21
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney 21
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? 21
Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients 21
Comparison of different cyclosporine immunoassays to monitor C-0 and C-2 blood levels from kidney transplant recipients: Not simply overestimation 21
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: Insights from the MYSS Trial 21
Practices of therapeutic drug monitoring in tuberculosis: an international survey. 21
Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts 21
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 21
Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once 20
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 20
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 20
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 20
Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation 20
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 20
When the absence of an interaction can become clinically relevant 20
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic 20
Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper 20
Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects 20
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 19
Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance 19
Effect of combining ACE inhibitor and statin in severe experimental nephropathy 19
Linezolid for extensively drug-resistant tuberculosis 19
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial 19
Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution? 19
[Functional loss of the transplanted kidney: immunological and non-immunological factors]. FT La perdita di funzione del rene trapiantato: fattori immunologici e non-immunologici 19
Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes 19
Severe hyperbilirubinemia in an HIV-HCV coinfected patient starting the 3D regimen that resolved after TDM-guided atazanavir dose reduction 19
Let's assume that hepatitis C reduces the cardiovascular risk in dialysis patients: Are there practical implications? 19
Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review 19
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: Insights from the mycophenolate steroid-sparing trial 19
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action 19
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation 19
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: Evidence from a safety study with pilot efficacy measures in adult dystrophic patients 19
How to fully protect the kidney in a severe model of progressive nephropathy: A multidrug approach 19
Management of Polypharmacy and Drug-Drug Interactions in HIV Patients: A 2-year Experience of a Multidisciplinary Outpatient Clinic 19
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges 19
Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation. 19
Investigational drugs for diabetic nephropathy 18
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients 18
Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection 18
From pharmacokinetics to pharmacogenomics: A new approach to tailor immunosuppressive therapy 18
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring 18
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring 18
Exposure-Related Effects of Atazanavir on the Pharmacokinetics of Raltegravir in HIV-1-Infected Patients 18
Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient 18
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 18
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation 18
Second generation antipsychotics in 'real-life' paediatric patients : adverse drug reactions and clinical outcomes of drug switch 18
Omega-3 Polyunsaturated Fatty Acids Affect Sirolimus Exposure in Kidney Transplant Recipients on Calcineurin Inhibitor-Free Regimen 18
Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges 18
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 18
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 18
The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir 18
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 18
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience 18
Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient 18
limited sampling strategies for the estimation of atazanavir dail exposure in HIV-1 infected patients 18
Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics? 18
Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives 18
Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study 18
Comment on "Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6" 18
Development of a CE method for the determination of mycophenolic acid in human plasma: A comparison with HPLC 18
Cyclosporine formulation and Kaposi's sarcoma after renal transplantation 18
Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution? 17
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation 17
Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients? 17
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection 17
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report 17
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics? 17
Totale 2.065
Categoria #
all - tutte 16.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 9 3 0 6 2 0 2
2021/202213 0 0 0 2 0 0 1 1 1 1 3 4
2022/202319 5 0 3 3 1 1 0 1 1 2 2 0
2023/202414 2 2 3 0 0 0 3 1 0 0 1 2
2024/202517 1 0 0 0 0 3 0 1 2 7 0 3
2025/20264.816 315 486 1.066 2.378 534 37 0 0 0 0 0 0
Totale 4.904